81
50
Growth Score 81 in past quarter
-5 pts
Heat Score 50 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
382827
Advancing treatments for rare diseases Together
Olivier Favre-Bulle: CMC ConsultantPast Role: Covance, European Executive Director of Bio/Pharmaceutical Solutions
About the Company
As a private non-for-profit organisation, they strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drug to reach these underserved patients.
